However, recently Hoerster and colleagues testes serum VEGF levels in a premature infant after one injection of ranibizumab to treat ROP 3 plus in zone I. They found suppressed systemic VEGF levels below detection limit for about 2 weeks post-injection. Here, VEGFA is linked to retinopathy of prematurity.